🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The ESTRO Focus Groups are recruiting! These groups will serve as the Society’s think-tanks in specific areas: tumour sites, treatment techniques, emerging technologies. 👉Apply now to join a Focus Group and start your journey as an active member ESTRO: bit.ly/44mhnjz

📣 Calling all radiation oncology professionals! Drive progress and help shape ESTRO initiatives in your field of interest. Put your expertise on the map by applying for an ESTRO Focus Group. ✅ We are looking forward to receiving your application!👉 bit.ly/44mhnjz

Join us on 29th Aug for this IASLC webinar on the role of radiotherapy in SCLC featuring Kristin Higgins and Antonin Lévy

Today Investigators Meeting of the ExclUsive endocRine Therapy Or Radiation theraPy for Women Aged ≥70 Years Early Stage #breastcancer (EUROPA) trial NCT04134598 - improving life of our patients #radonc #medonc #OncoAlert ESTRO OncoAlert

New perspectives for enhancing treatment personalization. Full paper online at authors.elsevier.com/a/1hqJg3K%7E8R…

Interesting session on multimodal treatment of HCC and the role of SBRT. Nice to see that our article on SBRT vs TACE has been appreciated 😌 marta scorsetti Tiziana Comito #ASTRO23

Onorata di parlare al webinar dal titolo “Il ruolo della SBRT nella gestione dei tumori epatici, sia primitivi che secondari” il 11/10 2pm, il primo webinar in italiano per l’International Stereotactic Radiosurgery Society - ISRS. Per iscriversi: isrsy.org/webinars/inter…

An intense morning with friends and colleagues, exploring the latest updates on the pathological classification of #genitourinary tumors and their implications in clinical practice. Thanks to SIUrO for this great opportunity! Humanitas University Humanitas Milano

ESTRO’s statement in support of the communities affected by the conflict in Israel.

Insightful webinar by Prof marta scorsetti on the role of SBRT for primary and secondary liver tumors. The first ISRSy webinar in Italian, with over 200 participants! #sbrt #livertumor #radiotherapy

Grazie alla Prof.ssa marta scorsetti per questi due anni nel gruppo oligo! In bocca al lupo a Mauro Loi come nuovo coordinatore! #airo2023 #oligometasticcancer

Today we celebrate 20 years of Radiotherapy and Radiosurgery Dept at Humanitas Milano. Over the years, the radiotherapy team, led by Prof marta scorsetti has passionately worked to provide quality care to patients. Ready to continue the journey of care, innovation, and research!

Congratulations to the new specialists Lorenzo Lo Faro and Marco Marzo for successfully completing the first cycle of the Residency school in Radiation Oncology of Humanitas University. Sure that you will continue with the same passion, good luck for a brilliant career 🌟👏marta scorsetti

Congratulazioni ai 6 candidati tecnici della 2’ edizione del Master di I livello in Tecniche avanzate di radioterapia oncologica, che hanno brillantemente discusso la loro tesi! #radiationoncology #radiotherapy Humanitas University Ciro Franzese

A systematic review and ISRS guidelines SBRT for primary kidney cancer is online The Lancet Oncology free link below authors.elsevier.com/c/1iMa25EIIgLq… Shankar Siva Simon Lo arjun sahgal Alison Tree 💙 Matthias Guckenberger

ISRSy - The Lancet Oncology primary kidney cancer guidelines below ⬇️ #radonc Sandro Porceddu Alex Louie MD, PhD Peter Mac Radiation Oncology Ben Slotman marta scorsetti

Virtual symposium by EORTC and ESTRO #OligoCare consortium 🔥 Hot topics and challenges in SBRT for oligometastatic disease 🔥 Do not miss these 🥇 speakers @drdavidpalma Shankar Siva Giulio Francolini Piet Ost and many more ! Registration 👇 eortc.org/event/virtual-…

Humanitas RT team ESTRO24 in Glasgow. Great opportunity to give our contribution to innovation in radiotherapy field and to learn about new advanced treatments . #ESTRO2024 #radiotherapy Humanitas University Humanitas Milano

Congratulations to prof. Barbara Jereczek-Fossa: she is the new president of ESTRO!!!@ESTRO_RT #ESTRO2024

💥💥💥SBRT and PT for Liver Oligometastatic CRC🔥🔥🔥 Thanks ASCO for the possibility to discuss this scenario! #ASCODailyNews #SBRT #Protontherapy ⬇️⬇️ dailynews.ascopubs.org/do/could-hypof…